Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Data from the REWIND trial suggest that dulaglutide has cardioprotective properties.
Read More »Dulaglutide Provides CVD Protection with or without Metformin
The Relationship Between Aerobic Exercise Capacity and Cardiac Dysfunction In T2D
In type 2 diabetes patients, treating diastolic function and myocardial perfusion reserve could improve aerobic exercise capacity and prevent heart failure.
Read More »Simple Strategies to Prevent Cardiovascular Complications in T2D
Explore three methods to prevent future acute myocardial infarction with diabetes as an underlying agent.
Read More »Heart Rate Variability as a Predictor for the Development of Diabetes
Decreased vagal tone and changes in sympathetic activity may precede the development of cardiometabolic disease or diabetes.
Read More »Jardiance Meets EMPEROR-Reduced Primary Endpoint
Diabetes drug shows benefit for heart failure patients with reduced ejection fraction.
Read More »Higher Intake of Protein Connected to Lower Mortality
Could a primarily plant-based high protein diet be the secret to longevity?
Read More »Reducing Cardiovascular Events and Mortality with Monthly Lifestyle Modification Counseling
Lifestyle modifications can impact cardiovascular outcomes including myocardial infarction, strokes, and death.
Read More »Long-Awaited Cardiovascular Efficacy and Safety Results From VERTIS-CV
Results from the VERTIS-CV trial suggest that ertugliflozin is not superior to placebo in reducing MACE but may reduce the rate of hospitalization for heart failure.
Read More »Sugar Intake Linked to Fat Deposits Around the Heart
Increased pericardial adipose tissue volume leads to coronary heart disease, coronary artery calcification, atrial fibrillation, and reduced left ventricular function.
Read More »Flu Vaccination for Better Diabetes Outcomes
Getting an annual flu vaccine could help lower complications associated with diabetes.
Read More »